Skip Navigation


Brain Advance Access originally published online on November 7, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/1/4    most recent
awh029v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (71)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hamani, C.
Right arrow Articles by Lozano, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamani, C.
Right arrow Articles by Lozano, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 127, No. 1, 4-20, 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh029


Review Article

The subthalamic nucleus in the context of movement disorders

Clement Hamani1, Jean A. Saint-Cyr1, Justin Fraser2, Michael Kaplitt2 and Andres M. Lozano1

1 Division of Neurosurgery, Toronto Western Hospital, Toronto Western Research Institute, Ontario, Canada and 2 Department of Neurological Surgery, Weill Medical College of Cornell University and Division of Neurosurgery, Memorial-Sloan Kettering Cancer Center, New York, NY, USA

Correspondence to: Andres M. Lozano Division of Neurosurgery, Toronto Western Hospital, West Wing 4-447, 399 Bathurst Street, Toronto, Canada ON M5T 2S8E-mail: lozano{at}uhnres.utoronto.ca or c.hamani{at}sympatico.ca

The subthalamic nucleus (STN) has been regarded as an important modulator of basal ganglia output. It receives its major afferents from the cerebral cortex, thalamus, globus pallidus externus and brainstem, and projects mainly to both segments of the globus pallidus, substantia nigra, striatum and brainstem. The STN is essentially composed of projection glutamatergic neurons. Lesions of the STN induce choreiform abnormal movements and ballism on the contralateral side of the body. In animal models of Parkinson’s disease this nucleus may be dysfunctional and neurons may fire in oscillatory patterns that can be closely related to tremor. Both STN lesions and high frequency stimulation ameliorate the major motor symptoms of parkinsonism in humans and animal models of Parkinson’s disease and reverse certain electrophysiological and metabolic consequences of dopamine depletion. These new findings have led to a renewed interest in the STN. The aim of the present article is to review briefly the major anatomical, pharmacological and physiological aspects of the STN, as well as its involvement in the pathophysiology and treatment of Parkinson’s disease.

Key Words: subthalamic nucleus; Parkinson’s disease; basal ganglia; deep brain stimulation; movement disorders

Abbreviations: AMPA = 2-aminomethyl-phenylacetic acid; BG = basal ganglia; CM = centromedian; EPSP = excitatory post-synaptic potential; GPe = globus pallidus externus; GPi = globus pallidus internus; HFS = high frequency stimulation; IPSP = inhibitory post-synaptic potential; mGluR = multiple glutamate receptors; MPTP = 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NMDA = N-methyl-D-aspartate; Pf = parafascicular; PPN = pedunculopontine nucleus; SNc = substantia nigra compacta; SNr = substantia nigra reticulata; STN = subthalamic nucleus

Received June 18, 2003. Revised September 3, 2003. Accepted September 8, 2003.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
K. Mukhida, M. Hong, G.B. Miles, T. Phillips, B.A. Baghbaderani, M. McLeod, N. Kobayashi, A. Sen, L.A. Behie, R.M. Brownstone, et al.
A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats
Brain, July 18, 2008; (2008) awn149v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
U. Strauss, F.-W. Zhou, J. Henning, A. Battefeld, A. Wree, R. Kohling, S. J.-P. Haas, R. Benecke, A. Rolfs, and U. Gimsa
Increasing Extracellular Potassium Results in Subthalamic Neuron Activity Resembling That Seen in a 6-Hydroxydopamine Lesion
J Neurophysiol, June 1, 2008; 99(6): 2902 - 2915.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. P. Lin, M. Carbon, C. Tang, A. Y. Mogilner, D. Sterio, A. Beric, V. Dhawan, and D. Eidelberg
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease
Brain, May 1, 2008; 131(5): 1373 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Feigin, M. G. Kaplitt, C. Tang, T. Lin, P. Mattis, V. Dhawan, M. J. During, and D. Eidelberg
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease
PNAS, December 4, 2007; 104(49): 19559 - 19564.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. Li, G. W. Arbuthnott, M. J. Jutras, J. A. Goldberg, and D. Jaeger
Resonant Antidromic Cortical Circuit Activation as a Consequence of High-Frequency Subthalamic Deep-Brain Stimulation
J Neurophysiol, December 1, 2007; 98(6): 3525 - 3537.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar, V. Dhawan, and D. Eidelberg
Changes in network activity with the progression of Parkinson's disease
Brain, July 1, 2007; 130(7): 1834 - 1846.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. E. Castner, H. J. Chenery, D. A. Copland, T. J. Coyne, F. Sinclair, and P. A. Silburn
Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease
Brain, May 1, 2007; 130(5): 1395 - 1407.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Asanuma, C. Tang, Y. Ma, V. Dhawan, P. Mattis, C. Edwards, M. G. Kaplitt, A. Feigin, and D. Eidelberg
Network modulation in the treatment of Parkinson's disease
Brain, October 1, 2006; 129(10): 2667 - 2678.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. S. Neimat, P. G. Patil, and A. M. Lozano
Novel Surgical Therapies for Tourette Syndrome
J Child Neurol, August 1, 2006; 21(8): 715 - 718.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. I. Kass and I. M. Mintz
Silent plateau potentials, rhythmic bursts, and pacemaker firing: Three patterns of activity that coexist in quadristable subthalamic neurons
PNAS, January 3, 2006; 103(1): 183 - 188.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G Foffani, A. M Bianchi, G Baselli, and A Priori
Movement-related frequency modulation of beta oscillatory activity in the human subthalamic nucleus
J. Physiol., October 15, 2005; 568(2): 699 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Maschke, P J Tuite, K Pickett, T Wachter, and J Konczak
The effect of subthalamic nucleus stimulation on kinaesthesia in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 569 - 571.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R. Hanajima, P. Ashby, A. M. Lozano, A. E. Lang, and R. Chen
Single Pulse Stimulation of the Human Subthalamic Nucleus Facilitates the Motor Cortex at Short Intervals
J Neurophysiol, September 1, 2004; 92(3): 1937 - 1943.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.